Systemic Areas · 5 min read
Parkinson’s and multiple sclerosis: what stem cell therapy can offer
A focus on symptoms and quality of life, what recent trials report, and how care is coordinated with your neurologist.
Short answer
In Parkinson’s disease and multiple sclerosis, stem cell therapy is offered as a complement to your neurologist’s treatment, with a focus on symptoms and quality of life. A 2025 randomised trial reported better motor function after intravenous mesenchymal stem cell infusions in mild to moderate Parkinson’s, and a meta-analysis in MS found most patients improved or remained stable.
In 30 seconds
- The focus is symptom support and quality of life, alongside your neurologist.
- Recent studies with intravenous infusions report encouraging results.
- A companion is recommended, and your coordinator plans every detail of the trip.
How can stem cells help in neurological conditions?
Mesenchymal stem cells release signals that modulate inflammation and support the environment around nerve cells. In neurodegenerative conditions, the goal is to support symptoms such as movement, fatigue and daily function, as part of the plan your neurologist leads.
What do studies report in Parkinson’s?
A randomised trial published in 2025 found that three intravenous infusions of mesenchymal stem cells improved motor function in people with mild to moderate Parkinson’s disease. Research continues to refine dosing, and patients in earlier stages are usually the best candidates.
And in multiple sclerosis?
In multiple sclerosis, the immune system damages myelin, the protective layer around nerve fibres. A 2023 meta-analysis found that about 40% of patients improved and a further 33% remained stable after mesenchymal stem cell therapy, with mostly mild side effects such as headache or fever.
How is care organised?
- A free review of your history and your neurologist’s report.
- An intravenous application in a single day at Hospital Puerta de Hierro Andares.
- A companion recommended for the whole stay, with a coordinator for every detail.
- Follow-up at 30, 90 and 180 days, with the family if you authorise it and a report for your neurologist.
Is this for you?
- You or a family member live with Parkinson’s or multiple sclerosis in an early or moderate stage.
- You are looking for support for symptoms and quality of life.
- Your neurologist’s report can be shared for the assessment.
Frequently asked questions
Who is a good candidate?
People in early or moderate stages, with a report from their neurologist, who are looking for symptom support and quality of life.
Does the medication continue?
Yes. Medication continues as the neurologist indicates, and any adjustment is made by them.
Should someone travel with the patient?
Yes, we recommend a companion for the whole stay. Your coordinator helps with transfers and accommodation.
How much does it cost?
Neurological protocols are quoted after a free medical assessment.
Stemlife Clinic at a glance
- Location
- Guadalajara, Mexico · Hospital Puerta de Hierro Andares
- Cells
- Mesenchymal stem cells from Wharton’s jelly (umbilical cord)
- Treatment
- One application in a single day; plan 2–3 days in Guadalajara
- Price
- From USD 5,000, confirmed after a free medical assessment
Medically reviewed by Dr. Guillermo Quezada Navarro · November 2026
Sources
General educational information. Individual results vary and are not guaranteed.
